Back to Agenda
Topic 2 Session 9 cont: Audits and Inspections in Pharmacovigilance – Industry Perspective
Speaker(s)
Audits and Inspections in Pharmacovigilance - Industry Perspective
Jonathan Rowell
Janssen Pharmaceutical Research & Development Quality & Compliance, United Kingdom
Director Regulatory Compliance
Have an account?